CVX vs ZBIO · P/E 17, rev $118.66B vs rev $10.0M
Chevron Corp (CVX) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Chevron Corp (CVX) is a oil & gas integrated company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
CVX currently screens at market cap $250.20B and trailing P/E 16.5. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the CVX and ZBIO stock pages for the full models.
Not investment advice.